These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 19231614)
1. Eltrombopag in chronic idiopathic thrombocytopenic purpura. Panzer S; Pabinger I Lancet; 2009 Feb; 373(9664):607-8. PubMed ID: 19231614 [No Abstract] [Full Text] [Related]
2. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632 [TBL] [Abstract][Full Text] [Related]
3. [Eltrombopag increases thrombocyte count and reduces the bleeding risk]. Med Monatsschr Pharm; 2007 Oct; 30(10):390-1. PubMed ID: 17966290 [No Abstract] [Full Text] [Related]
4. Sustaining platelet counts in chronic ITP. Nurden AT Lancet; 2011 Jan; 377(9763):358-60. PubMed ID: 20739056 [No Abstract] [Full Text] [Related]
5. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura. Bussel JB; Cheng G; Saleh MN; Psaila B; Kovaleva L; Meddeb B; Kloczko J; Hassani H; Mayer B; Stone NL; Arning M; Provan D; Jenkins JM N Engl J Med; 2007 Nov; 357(22):2237-47. PubMed ID: 18046028 [TBL] [Abstract][Full Text] [Related]
6. Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations. Cook L; Cooper N Drug Des Devel Ther; 2010 Jul; 4():139-45. PubMed ID: 20689640 [TBL] [Abstract][Full Text] [Related]
7. Severe cutaneous toxicity related to Eltrombopag. Meyer SC; Rovó A; Tsakiris DA; Scherer K; Tichelli A; Holbro A Br J Haematol; 2013 Feb; 160(3):412-4. PubMed ID: 23151239 [No Abstract] [Full Text] [Related]
8. Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura. Dmytrijuk A; Robie-Suh K; Rieves D; Pazdur R Oncology (Williston Park); 2009 Nov; 23(13):1171-7. PubMed ID: 20043468 [TBL] [Abstract][Full Text] [Related]
18. Eltrombopag. Idiopathic thrombocytopenic purpura after treatment failure: romiplostim is a better option. Prescrire Int; 2010 Feb; 19(105):15. PubMed ID: 20455333 [TBL] [Abstract][Full Text] [Related]
19. Eltrombopag for use in children with immune thrombocytopenia. Kim TO; Despotovic J; Lambert MP Blood Adv; 2018 Feb; 2(4):454-461. PubMed ID: 29487060 [TBL] [Abstract][Full Text] [Related]